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Intracellular fluctuations of the second messenger cyclic AMP (cAMP) are regulated
with spatial and temporal precision. This regulation is supported by the sophisticated
arrangement of cyclases, phosphodiesterases, anchoring proteins, and receptors for
cAMP. Discovery of these nuances to cAMP signaling has been facilitated by the
development of genetically encodable tools for monitoring and manipulating cAMP and
the proteins that support cAMP signaling. In this review, we discuss the state-of-the-art
in development of different genetically encoded tools for sensing cAMP and the activity
of its primary intracellular receptor protein kinase A (PKA). We introduce sequences
for encoding adenylyl cyclases that enable cAMP levels to be artificially elevated
within cells. We chart the evolution of sequences for selectively modifying protein–
protein interactions that support cAMP signaling, and for driving cAMP sensors and
manipulators to different subcellular locations. Importantly, these different genetically
encoded tools can be applied synergistically, and we highlight notable instances that
take advantage of this property. Finally, we consider prospects for extending the utility
of the tool set to support further insights into the role of cAMP in health and disease.
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Introduction
The discovery that some hormones elevate the second messenger cyclic AMP (cAMP) without
triggering canonical eﬀects such as increased phosphorylase activity (Keely, 1979; Hayes et al.,
1980) indicated that cAMP may be compartmentalized in cells (Edwards et al., 2012). Studies
of cAMP compartmentalization rely upon methods to sense and manipulate signaling enzyme
activities in space and time (Scott and Pawson, 2009). The ﬁrst sensor of intracellular cAMP
(‘FlCRhR’) was constructed by ﬂuorescein-labeling PKA catalytic subunits and rhodamine-labeling
the regulatory subunits of the tetrameric kinase (Adams et al., 1991). Release of the catalytic
subunits upon binding of cAMP to the regulatory subunits can be detected as a reduction in Forster
resonance energy transfer (FRET; Adams et al., 1991). The FlCRhR probe was revolutionary as it
enabled the ﬁrst visualizations of cAMP compartmentalization (Bacskai et al., 1993; Hempel et al.,
1996). However, the sensor must be microinjected since its ﬂuorescent labels are not genetically
encoded. This technical hurdle has limited the inﬂuence of the FlCRhR probe.
The subsequent development of genetically encoded sensors of cAMP (Zaccolo et al., 2000)
and PKA activity (Zhang et al., 2001), in tandem with methods for manipulating both the
enzyme that synthesizes cAMP – adenylyl cyclase (AC) – and molecular interactions that
support cAMP signaling, has initiated a new wave of discoveries concerning cAMP signaling
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(Edwards et al., 2012). Studies with these novel tools have
helped to establish the necessity for targeting PKA to its
substrates by anchoring to A-kinase anchoring proteins (AKAPs;
Rosenmund et al., 1994; Zhang et al., 2001; Di Benedetto et al.,
2008). The tools have been applied to reveal a small nuclear
population of anchored PKA (Sample et al., 2012). Furthermore,
they have illuminated how PKA interacts spatiotemporally
with phosphodiesterase (PDE) enzymes that degrade cAMP
(Willoughby et al., 2006), with the exchange-protein activated
by cyclic AMP (Epac; Dodge-Kafka et al., 2005), and with Ca2+
signals (Cooper and Tabbasum, 2014). This genetically encoded
tool set has also been applied to establish a role for localized
cAMP signaling in diseases (Gold et al., 2013b) such as heart
failure (Nikolaev et al., 2010), muscular dystrophy (Roder et al.,
2009), diabetes (Zhang et al., 2005), breast cancer (Hansen et al.,
2009), and adrenal Cushing’s syndrome (Beuschlein et al., 2014).
In this review, we introduce genetically encoded sensors
of cAMP and PKA activity, before discussing tools based
upon ACs. We describe sequences that are available for
targeting such tool proteins to speciﬁc sub-cellular locations and
for modifying protein interactions involving cAMP signaling
proteins. Importantly, further functionality can arise when the
diﬀerent classes of tools are combined, and we highlight studies
that exploit this kind of synergy. Finally, we consider how the
tool set might be extended and combined in novel ways to enable
further advances in the understanding of cAMP signaling.
Genetically Encoded Sensors for
Monitoring cAMP Dynamics
There are three types of cAMP receptors in higher organisms:
PKAs, Epacs, and cyclic-nucleotide-gated channels (CNGCs).
Genetically encoded sensors are available that derive from each
class of endogenous cAMP receptor (Willoughby and Cooper,
2008). Sensors derived from PKAs and Epacs rely upon fusions
to variants of green ﬂuorescent protein (GFP) that undergo
decreased FRET upon elevation of cAMP. Sensors derived from
CNGCs can also employ measurements using patch clamp
electrophysiology to detect changes in conductance upon binding
of cAMP to the channel. The ﬁrst genetically encoded FRET-
based cAMP sensor was constructed by fusing an improved GFP
to the C-terminus of the PKA catalytic subunit and a blue GFP
variant (EBFP) to the C-terminus of type-II regulatory (RII) PKA
subunits (Zaccolo et al., 2000). Respective substitution of EBFP
and GFP with cyan and yellow ﬂuorescent proteins yielded an
improved sensor that is less prone to photobleaching (Zaccolo
and Pozzan, 2002). This allowed real time imaging of cAMP
ﬂuctuations in cardiomyocytes in response to the β-adrenergic
agonist norepinephrine or the broad spectrum PDE inhibitor
isobutyl-methyl-xanthine (IBMX), and helped to establish that
type IV PDEs are the critical PDE class for degrading cAMP
following activation with norepinephrine in cardiomyocytes
(Mongillo et al., 2004).
The discovery of Epac1 and Epac2 (de Rooij et al., 1998;
Kawasaki et al., 1998) opened the door for development of
unimolecular cAMP sensors based upon these cAMP-dependent
GTPase activators (DiPilato et al., 2004; Nikolaev et al., 2004;
Ponsioen et al., 2004). Unimolecular sensors based on Epacs
exhibit higher FRET eﬃciency (increase in FRET signal from
maximal to minimal cAMP) of ∼20–30% compared to ∼8%
for multimolecular PKA-based sensors. Epac probes also show
better temporal resolution (Nikolaev et al., 2004), and there
are no concerns regarding balancing expression of the donor
and acceptor ﬂuorophores in unimolecular probes. For these
reasons, Epac probes are now the most popular option for
sensing cAMP ﬂuctuations. The latest optimized Epac-based
probes include pH-insensitive Ci/Ce Epac2-camps (Everett and
Cooper, 2013) (Figure 1A) and the Epac1-based probes ICUE3
(DiPilato and Zhang, 2009) and TEpacVV (Klarenbeek et al., 2011;
Li et al., 2015) although the original probes exhibit good FRET
eﬃciency and are still popular. CNGC-based cAMP sensors
excel in temporal resolution of cAMP ﬂuctuations (Rich et al.,
2000; Fagan et al., 2001). The ﬁrst example of this approach
exploited rat CNG2 expression in human embryonic kidney-
293 (HEK-293) cells (Rich et al., 2000). Measurement of Ca2+
ﬂux through the channels as a proxy for cAMP elevation using
electrophysiology supported the existence of cellular cAMP
microdomains. Mutations can be incorporated into the CNG2 to
tailor it for sensing cAMP: C460W improves cAMP sensitivity,
E583M improves cAMP speciﬁcity over cGMP, and removal of
residues 61-90 abrogates channel regulation by Ca2+/calmodulin
(Rich et al., 2001) (Figure 1B). A C460W/E583M double
CNG2 mutant was used as a sensor to reveal that both G
protein coupled receptor kinases (GRKs) and PKA stimulate
PDE degradation of cAMP following β2-AR simulation of
HEK-293 cells (Xin et al., 2008). A common way to apply
CNG2 is to combine expression of the channel with the
Ca2+ dye Fura-2, allowing measurement of Ca2+ inﬂux by
imaging rather than electrophysiology (Fagan et al., 2001; Rich
et al., 2001, 2007; Rochais et al., 2004). For example, the
E583M CNG2 variant was applied in this way to establish the
necessity of PKA anchoring for negative feedback through PKA
activation of type IV PDEs (Willoughby et al., 2006). CNGCs
can also be adapted as FRET sensors (Nikolaev et al., 2006).
The hyperpolarization-activated CNG2 (HCN2) has a higher
sensitivity than CNG2, and exhibits as wide a dynamic range
as a cAMP FRET sensor when YFP and CFP are fused either
side of a single HCN2 cAMP binding domain (Nikolaev et al.,
2006).
Genetically encoded cAMP probes have been applied to
investigate diﬀerent facets of cAMP signaling. For example, they
have helped build upon initial observations of cAMP oscillations
in Brooker (1973) and Gorbunova and Spitzer (2002). Epac-
based probes demonstrate that cAMP oscillations can be evoked
in cell lines including MIN6 cells (Landa et al., 2005) and
HEK293 cells (Willoughby and Cooper, 2006). cAMP oscillations
have also been monitored in β-cells using evanescent-wave-
microscopy in combination with ﬂuorescently labeled RII-CAAX
and C subunits (Dyachok et al., 2008). This approach shows
that Ca2+ ampliﬁes but is not essential for glucose-induced
cAMP oscillations in β-cells (Dyachok et al., 2008). Ca2+
typically oscillates in tandem with cAMP, and a related area
of focus has been the basis of interplay between cAMP and
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FIGURE 1 | Tools for monitoring cyclic AMP (cAMP) signaling. Two cAMP
sensors and an A-kinase activity reporter are illustrated. (A) Cartoon showing
mechanism for cAMP sensing by ‘Ci/C-Epac2-camps,’ which is based on the
second cAMP binding domain of Epac2. Elevation of cAMP leads to separation
of citrine and cerulean fluorescent proteins that can be detected as a decrease
in FRET (B) cAMP sensor based on cyclic nucleotide-gated channel 2 (CNG2),
which is modified with removal of residues 61–90 to prevent Ca2+/calmodulin
regulation, and the substitutions C460W/E583M for high affinity and specificity
for cAMP. Elevation of cAMP leads to increased flux of Ca2+ which can be
detected using Ca2+ dyes or by measuring current across the membrane.
(C) AKAR4 contains a central FHA1 domain. PKA phosphorylation of threonine
within the motif ‘LRRATLVD’ leads to association of phosphothreonine with
FHA1, which can be detected as an increase in FRET between the terminal
fluorescent proteins.
Ca2+ signals at the level of signaling proteins. Epac probes
reveal that distinct pools of cAMP center on speciﬁc isoforms
of AC (Wachten et al., 2010), with the Ca2+-activated cyclase
AC8 occupying a prominent role in linking Ca2+ signals to
localized cAMP elevation (Willoughby et al., 2010; Ayling et al.,
2012).
A key advantage of genetically encoding sensors is that
transgenic animals expressing the sensors can be generated.
Imaging of cAMP ﬂuctuations has been achieved in pancreatic
islets (Kim et al., 2008) using genetically engineered mice that
selectively express a PKA-based cAMP sensor in pancreatic islets.
This approach was exploited to show that that glucose triggers
cAMP elevation independent of Ca2+ (Kim et al., 2008). Another
study monitored cAMP changes upon activation of either β1
or β2 adrenergic receptors within small sarcolemmal areas
by employing adrenergic receptor knockout mice transgenically
expressing Epac2-camps (Nikolaev et al., 2010). This study
revealed that β2 adrenergic receptors are restricted to deep
transverse tubules (Nikolaev et al., 2010). Development of
transgenic fruit ﬂies expressing cAMP sensors (Lissandron et al.,
2007) has also proved to be useful. In particular, Drosophila
expressing Epac1-camps with an upstream activating sequence
for GAL4 (Shafer et al., 2008) have enabled detailed investigation
of how neuropeptides including pigment dispersing factor
modulate cAMP in neurons during circadian rhythms (Duvall
and Taghert, 2012; Pirez et al., 2013; Vecsey et al., 2014; Yao
and Shafer, 2014). In sum, an impressive array of sensors and
delivery options are now available for monitoring intracellular
cAMP ﬂuctuations.
Fluorescence-Based Sensors for
Monitoring PKA Activity
One potential limitation of cAMP sensors is that they may
not reﬂect cAMP receptor activation if the receptors and active
cyclase are not co-localized. For PKA, genetically encoded
A-kinase activity reporters (AKARs) may be utilized to monitor
kinase activity more directly (Mehta and Zhang, 2011). The ﬁrst
AKAR was constructed by placing YFP and CFP either side
of a PKA consensus phosphorylation sequence derived from
Kemptide and the phospho-serine/threonine-binding protein
Frontiers in Pharmacology | www.frontiersin.org 3 August 2015 | Volume 6 | Article 164
Patel and Gold cAMP tool synergy
14-3-3τ (Zhang et al., 2001). Phosphorylation at the PKA
consensus sequence causes association of the central elements
that may be detected as a concomitant increase in FRET
(Zhang et al., 2001). A second-generation sensor, AKAR2,
incorporates a Forkhead-associated (FHA) domain in tandem
with a lower aﬃnity PKA recognition site. This modiﬁcation
improves the reversibility of the reporter (Zhang et al., 2005).
This reporter was ﬁrst applied to investigate interaction of insulin
and isoproterenol stimulation of adipocytes. Using AKAR2,
the authors found that chronic insulin treatment delayed PKA
activation following addition of low concentrations of the β-AR
agonist isoproterenol (Zhang et al., 2005). Conversely, PKA
response to stimulation with either forskolin or caged cAMP was
not aﬀected by prior chronic insulin treatment. This suggested
that insulin reduces PKA localization to a pool of cAMP
associated with β-ARs. This notion was corroborated by anti-
β-AR immunoprecipitation experiments that revealed decreased
interaction of PKA RII subunits with β-ARs following dual
treatment with insulin and isoproterenol (Zhang et al., 2005).
This detail might have been missed if a cAMP sensor had
been employed rather than AKAR2. Systematic improvement of
AKAR reporters is ongoing (Liu et al., 2011; Oldach and Zhang,
2014). The latest reporter, AKAR4, features the ﬂuorescent
protein variants Cerulean and cpVenus (Depry et al., 2011)
(Figure 1C).
A-kinase activity reporters have also been widely applied. For
example, they have been used to validate stapled PKA anchoring
disruptor peptides (Wang et al., 2014), and to conﬁrm that
Leu206Arg substitution in Cα subunits (associated with Adrenal
Cushing’s Syndrome) leads to constitutive kinase activation
(Beuschlein et al., 2014). They are often utilized in parallel
with cAMP sensors, for example, in imaging ﬂuctuations of
cAMP and PKA activity induced by neural activity in retinal
cells (Dunn et al., 2006); to investigate cAMP/PKA dynamics
at the centrosome (Terrin et al., 2012); and in the study of
neurite outgrowth including a forskolin-coated glass bead contact
procedure for cultured hippocampal neurons (Shelly et al., 2010).
As with genetically encoded cAMP sensors, it is possible to
express AKARs in transgenic animals. For example, PKA activity
dynamics have been imaged in Drosophila expressing AKAR2
(Gervasi et al., 2010). In this study, Kamioka et al. (2012)
performed crosses with learning and memory deﬁcient mutant
ﬂy lines to establish that the AC Rutabaga acts as a coincidence
detector during aversive and appetitive learning (Gervasi et al.,
2010). AKAR-expressing mice have also been developed, and
exploited to image real-time PKA activity in mouse epidermis
and small intestine (Kamioka et al., 2012). These whole-organism
studies underline the beneﬁts of genetically encoding reporters in
comparison to techniques that rely upon microinjection (Adams
et al., 1991).
Tools for Manipulating Adenylyl Cyclase
Activity
The ability to control cAMP elevations with spatiotemporal
precision can help to reveal how cAMP signaling is organized in
time and space (Scott and Pawson, 2009). In analogous fashion to
the discovery of light-activated channelrhodopsins for artiﬁcially
depolarizing cells (Nagel et al., 2003), photo-active adenylyl
cyclases (PACs) have been identiﬁed in photo-sensitive microbes
(Iseki et al., 2002; Ryu et al., 2010; Stierl et al., 2011). Advantages
of genetically encoded PACs over cAMP uncaging approaches
(Ponsioen et al., 2004; Saucerman et al., 2006) include the ability
to deliver into whole animals, and the option to localize the
PAC within cells by fusion to subcellular targeting sequences.
The ﬁrst PAC to be characterized and utilized was discovered in
Euglena.This unicellular ﬂagellate relies on a PAC in photophobic
behavior (Iseki et al., 2002). Euglena PAC comprises two subunits,
PACα and PACβ. Each subunit consists of two blue light receptor
using ﬂavin adenine nucleotide (BLUF) domains paired with two
AC domains. Activation of the BLUF domains with blue light
leads to a conformational change that activates the AC domains.
Both PAC subunits respond to blue light with a maximal increase
in AC activity of∼80-fold. The PACα subunit is more active than
PACβ in both light and dark conditions (Iseki et al., 2002), so
applications of Euglena PAC have utilized the α subunit (Bucher
and Buchner, 2009; Bellmann et al., 2010; Weissenberger et al.,
2011).
Smaller PACs have subsequently been discovered in species
other than Euglena, including Beggiatoa PAC (bPAC; Ryu et al.,
2010; Stierl et al., 2011) (Figure 2A). bPAC comprises 350
residues, which facilitates transgenic delivery in comparison to
PACα (1019 residues). bPAC also exhibits better responsiveness
to blue light than PACα, and cyclase activity decreases faster
for bPAC upon return to the dark (Ryu et al., 2010; Stierl
et al., 2011). A diﬀerent class of PAC has been identiﬁed in
Microcoleus (mPAC) that relies on a blue light-responsive light
oxygen voltage domain coupled to an AC domain (Raﬀelberg
et al., 2013). mPAC compares favorably to bPAC when expressed
FIGURE 2 | Tools for triggering cAMP elevation. (A) Illustration of
Beggiatoa PAC (bPAC) demonstrating how light illumination of the BLUF
domain is coupled to activation of AC activity. (B) A truncated version of
soluble AC (sACt) responds to elevated bicarbonate by catalyzing cAMP
synthesis.
Frontiers in Pharmacology | www.frontiersin.org 4 August 2015 | Volume 6 | Article 164
Patel and Gold cAMP tool synergy
in vivo, although its responsiveness to blue light is worse in vitro,
suggesting that a cellular co-factor may support its proper
function (Raﬀelberg et al., 2013). Both bPAC and mPAC require
lower light intensity for cyclase activation than PACα (Ryu et al.,
2010; Stierl et al., 2011; Raﬀelberg et al., 2013), so are better
suited for application in tissue samples where light penetration
is a challenge. A noteworthy alternative to PACs is to employ
a C-terminally truncated version of soluble AC (sACt) that can
be activated by addition of bicarbonate (Sample et al., 2012)
(Figure 2B). This approach is compatible with simultaneous
monitoring of cAMP concentration and PKA activity with
FRET-based probes (Sample et al., 2012; see Combinatorial
Applications).
The utility of PACs is demonstrated by studies up to the
level of whole animals. PACα has been expressed in cholinergic
neurons (Weissenberger et al., 2011), motor neurons (Bucher
and Buchner, 2009), and olfactory receptor neurons (ORNs;
Bellmann et al., 2010) inDrosophila. This has enabled conceptual
progress including the establishment of a speciﬁc class of ORNs
that mediate olfactory avoidance behavior (Bellmann et al.,
2010). PACα has been applied to demonstrate a key role for
cAMP in growth cone turning in Xenopus (Nicol et al., 2011).
Nicol et al. (2011) found that local pulses of blue light on
distal parts of growth cones expressing PACα were suﬃcient
to maintain orientation of axon outgrowth toward the midline
despite blockade of a key Netrin-1 receptor. The potential utility
of bPAC has been demonstrated in Aplysia (Nagahama et al.,
2007), Toxoplasma (Hartmann et al., 2013), and in Xenopus,
HEK293 cells and Drosophila (Schroder-Lang et al., 2007).
Jansen et al. (2015) have shown how bPAC can be used to
control sperm motility and maturation. Furthermore, speciﬁc
expression of bPAC in Drosophila renal tubule in combination
with pharmacological manipulations has revealed the distinct
roles fulﬁlled by PKA and Epac in controlling secretion from
principal and stellate cells (Efetova et al., 2013). The ﬁeld is
poised for further insights as application of PACs becomes more
widespread.
Sequences for Subcellular Targeting and
Modifying Protein–Protein Interactions
An important characteristic of genetically encoding sensors and
manipulators of cAMP signaling is that they can be combined
with targeting sequences to direct them to speciﬁc subcellular
compartments. This approach facilitates investigation of spatial
aspects of cAMP signaling. In addition, a number of sequences
are available for manipulating interaction between PKA and its
anchoring sites. A straightforward way to control the location
of a given genetically encoded tool is to fuse it with a full-
length signaling protein of interest. This option has been taken
with proteins including AC8 (Willoughby et al., 2012, 2014;
Everett and Cooper, 2013), full-length PKA RII (Zhang et al.,
2001), diﬀerent PDEs (Herget et al., 2008), SOD2 (Zhang et al.,
2015), phospholamban (Sprenger et al., 2015), and Hsp20 (Sin
et al., 2011). In cases where a good structural understanding is
available, fusions are possible to shorter protein domains, such
as with the dimerization and docking (D/D) domain of PKA
regulatory subunits for tethering at anchoring sites (Di Benedetto
et al., 2008), or with the PDE4D-association region frommAKAP
(Dodge-Kafka et al., 2005).
The structural interface between PKA and AKAPs is well
understood: all AKAPs present a ∼20 amino acid amphipathic
helix that binds within a shallow hydrophobic groove on the D/D
domain of PKA regulatory subunits (Gold et al., 2006; Kinderman
et al., 2006; Sarma et al., 2010). Native and synthetic AKAP
anchoring helix sequences are available for modifying PKA
anchoring or targeting genetically encoded tools including cAMP
sensors (summarized in Table 1). A popular sequence is Ht31
(Rosenmund et al., 1994), which is the native anchoring helix of
AKAP-Lbc. Using a combination of structural information and
peptide array screening, synthetic sequences have been developed
with altered binding preferences for RI and RII PKA regulatory
subunits. These include the RII-selective sequences AKAP-is
(Alto et al., 2003), Super-AKAP-is (Gold et al., 2006), and AKB-
II (Burns-Hamuro et al., 2003); and the RI-selective sequences
RIAD (Carlson et al., 2006; Torheim et al., 2009) and AKB-
RI (Burns-Hamuro et al., 2003). Studies that utilize sequences
for modifying protein–protein interactions typically apply them
exogenously as peptides, such as stearated Ht31 (Gold et al.,
2012), and delivery approaches in this vein are still improving
(Wang et al., 2014, 2015). Some studies have taken advantage
of their genetic encodability. For example, sequences including
AKAP-is (Dodge-Kafka et al., 2005) and AKB-RI/RII (Burns-
Hamuro et al., 2003) have been expressed using transfection, and
Ht31 has been incorporated in a transgenic mouse (Park et al.,
2014).
An additional recent innovation is the development of variants
of PKA regulatory subunits with selective anchoring properties
(Gold et al., 2013a). A structure-based bacteriophage screening
procedure (Walker-Gray and Gold, 2015) enabled identiﬁcation
of variants of the RII D/D domain with substitutions that
enable selective anchoring to AKAP18 and AKAP2 (Gold et al.,
2013a). RSelect subunits can potentially be applied to drive
PKA either speciﬁcally to or away from individual AKAPs
(Gold et al., 2013a). In most tissues, with rare exceptions (Gold
et al., 2012), multiple AKAPs are present and an important
challenge is to identify the PKA substrates associated with
diﬀerent AKAP–PKA signaling complexes (Gold et al., 2013b).
It is possible to genetically abrogate speciﬁc PKA anchoring sites,
for example, in the case of AKAP150 PKA knock-in mice in
which the PKA anchoring helix in AKAP150 is absent (Murphy
et al., 2014). Therefore, a potentially more novel application of
RSelect subunits is to combine them with anchoring disruptors
such as Ht31. This approach enables PKA catalytic subunits
to be driven to a single AKAP within the cell (Gold et al.,
2013a).
A variety of sequences may be utilized for targeting to
organelles (Table 1). Inclusion of C-terminal polybasic-CAAX
sequences enables targeting to the plasma membrane (DiPilato
et al., 2004; Dyachok et al., 2006; Saucerman et al., 2006;
Depry et al., 2011), whereas N-terminal addition of a sequence
derived from Lyn kinase targets speciﬁcally to cholesterol-rich
regions of plasma membrane (Terrin et al., 2006; Depry et al.,
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TABLE 1 | Sequences for modifying interactions between cyclic AMP (cAMP) signaling proteins and subcellular targeting.
Purpose Name and specifications Reference
Sequences for modifying protein–protein interactions
Binding to the D/D domain of
PKA RII subunits
Ht31 (AADLIEEAASRIVDAVIEQVKA). KD = 2.2 nM for RIIα; 1.3 μM for
RIα
Rosenmund et al. (1994), Alto et al. (2003)
AKAP-is (QIEYLAKQIVDNAIQQA). KD = 0.4 nM for RIIα, 277 nM for RIα Alto et al. (2003), Dodge-Kafka et al. (2005)
Super-AKAP-is (QIEYVAKQIVDYAIHQA). On filter assay binds RIIα 4×
more and RIα 12.5× less efficiently than AKAP-is
Gold et al. (2006)
AKB-RII (VQGNTDEAQEELLWKIAKMIVSDVMQQ). KD = 2.7 nM for
RIIα, 2.5 μM for RIα
Burns-Hamuro et al. (2003)
Binding to the D/D domain of
PKA RI subunits
RIAD (LEQYANQLADQIIKEATE). KD = 1 nM for RIα, 1800 nM for RIIα Carlson et al. (2006), Torheim et al. (2009)
AKB-RI (FEELAWKIAKMIWSDVFQQ). KD = 5.2 nM for RIα; 450 nM for
RIIα
Burns-Hamuro et al. (2003)
Localizing with type I PKA RIα (1–64) Di Benedetto et al. (2008)
Binding to AKAP anchoring
helices
RIIβ (amino acids 1–49) Di Benedetto et al. (2008)
Specifically binding to the
AKAP18 anchoring helix
RSelectAKAP18 (PKA RIIα 1–45 with I3V, I5L, T10D, Q14G
substitutions)
Gold et al. (2013a)
Binding to PDE4D mAKAP (1286–1831) Dodge-Kafka et al. (2005)
Sequences for subcellular targeting
Plasma membrane C-terminal addition of polybasic-CAAX sequence, e.g.,
GKKKKKKSKTKCVIM. CAAX box undergoes farnesylation
DiPilato et al. (2004), Dyachok et al. (2006),
Saucerman et al. (2006), Depry et al. (2011)
Plasma membrane
(cholesterol-rich)
N-terminal addition of Lyn kinase sequence, e.g.,
MGCIKSKRKDNLNDD, that undergoes myristoylation and
palmitoylation
Terrin et al. (2006), Depry et al. (2011),
Sample et al. (2012)
Nuclear localization C-terminal addition of nuclear localization signal PKKKRKVEDA DiPilato et al. (2004), Terrin et al. (2006),
Sample et al. (2012)
Nuclear export C-terminal addition of nuclear export sequence LPPLERLTL Sample et al. (2012)
Sarcoplasmic reticulum C-terminal addition of the helical transmembrane region
(PQQARQKLQNLFINFCLILICLLLICIIVMLL) of phospholamban
Liu et al. (2011)
Outer mitochondrial membrane N-terminal addition of the targeting peptide yTom70 Lefkimmiatis et al. (2013)
N-terminal addition of MitoDAKAP1
(MAIQLRSLFPLALPGMLALLGWWWFFSRKK), a mitochondrial signal
sequence derived from D-AKAP1
Burns-Hamuro et al. (2003), DiPilato et al.
(2004), Lim et al. (2007), Depry et al. (2011)
Mitochondrial matrix N-terminal addition of the mitochondrial matrix targeting signal encoded
in the first 12 amino acids of subunit IV of human cytochrome oxidase c
DiPilato et al. (2004), Lefkimmiatis et al.
(2013)
2011; Sample et al., 2012). C-terminal addition of the sequence
‘PKKKRKVEDA’ enables nuclear localization (DiPilato et al.,
2004; Terrin et al., 2006; Sample et al., 2012), whereas addition
of ‘LPPLERLTL’ at the same terminus drives nuclear export
(Sample et al., 2012). Targeting to the sarcoplasmic reticulum
is possible by fusing with the helical transmembrane domain
of phospholamban (Liu et al., 2011). Furthermore, sequences
are available for targeting to both the outer mitochondrial
membrane (OMM; Burns-Hamuro et al., 2003; DiPilato et al.,
2004; Lim et al., 2007; Depry et al., 2011; Lefkimmiatis et al.,
2013), and to the mitochondrial matrix (DiPilato et al., 2004;
Lefkimmiatis et al., 2013). At the whole animal level, systems
are also available for driving cell-type speciﬁc expression of
genetically encoded tools. These include the UAS/GAL4 system
in Drosophila (Shafer et al., 2008), and the reverse tetracycline
transactivator (rtTA)/doxycycline system in transgenic mice
(Kim et al., 2008). Overall, there is an impressive arsenal of
sequences at the experimenter’s disposal for manipulating the
location and binding properties of cAMP signaling proteins and
genetically encoded tools.
Combinatorial Applications
The tools described in this review have been combined in
diﬀerent ways to make conceptual breakthroughs that would not
have been possible if the tools were applied in isolation. The
majority of combinations consist of fusions to either sequences
derived from cAMP signaling proteins or to subcellular targeting
sequences.Wewill also consider two exceptional studies that have
utilized highly innovative combinations of the tool set (Ni et al.,
2011; Sample et al., 2012).
The ﬁrst study involving AKAR1 set a precedent for
combining a cAMP sensor with sequences derived from cAMP
signaling proteins. Fusion of AKAR1 to the PKA RII subunit
revealed that PKA phosphorylation occurs more quickly if PKA
is tethered in proximity to its substrate (Zhang et al., 2001).
This ﬁnding underlined the importance of anchoring PKA to
its substrates. A similar approach has been to fuse an Epac-
based cAMP sensor to AC8 (Willoughby et al., 2012, 2014), for
example, to demonstrate that this Ca2+-sensitive AC responds
to Ca2+ entering through L-type Ca2+ channels (Everett and
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Cooper, 2013). Fusions to isolated domains of cAMP signaling
proteins have also been insightful. Fusing Epac-based sensors to
the D/D domains of diﬀerent PKA regulatory subunit classes
(Di Benedetto et al., 2008; Roder et al., 2009) has helped to
establish that PDE4 associates with RII subunits, whereas PDE2
acts in the vicinity of RI subunits (Di Benedetto et al., 2008).
By applying this approach in cardiomyocytes, Di Benedetto et al.
(2008) also revealed that the β-AR agonist isoproterenol triggers
relatively higher cAMP accumulation with RII subunits, whereas
hormones including glucagon induce raised cAMP in the vicinity
of the RI subunit. This mechanism allows G protein-coupled
receptor speciﬁc patterns of cAMP signaling to occur within
the same cell. A fusion of the PDE-binding region of mAKAP
(residues 1286–1831) with the AKAR2 reporter has also been
applied to demonstrate that dominant active MEK5 prolongs
PKA activity after cAMP elevation with forskolin (Dodge-Kafka
et al., 2005).
Targeting FRET-based sensors using subcellular targeting
sequences has also proved to be valuable. Fusions of AKAR
reporters with membrane-targeting sequences (Saucerman et al.,
2006; Depry et al., 2011) have revealed, for example, that
basal PKA activity is higher in cholesterol-rich ‘raft’ regions of
membrane (Depry et al., 2011). Similarly, plasma membrane-
targeting of an Epac-based cAMP sensor has helped to
establish how a pre-assembled protein complex including RXFP1,
AKAP79, AC2, β-arrestin 2, and PDE4D3 enables responses
to sub-picomolar circulating concentrations of relaxin peptide
(Halls and Cooper, 2010). Comparison of PKA activity using
AKAR4 targeted to either the mitochondrial matrix or OMM
shows that PKA phosphorylation is more enduring at the OMM
than in the cytosol due to diminished phosphatase activity at
the OMM (Lefkimmiatis et al., 2013). A related approach has
been to fuse a sequence that targets to the outer mitochondrial
membrane to the PKA regulatory subunit-speciﬁc anchoring
disruptors AKB-R1 and AKB-R2 (Lim et al., 2007). Lim et al.
(2007) expressed these fused sequences to prevent access of either
type I or type II PKA to the plasma membrane. This approach
revealed that leading-edge phosphorylation of PKA substrates
requires type I PKA, with re-localization of type I PKA to the
mitochondria inhibiting both the directional persistence and
speed of cell migration (Lim et al., 2007).
Two highly innovative combinatorial approaches have been
exploited to examine cAMP dynamics in recent years (Terrin
et al., 2006; Sample et al., 2012). Sample et al. (2012) developed
a novel technique called spatiotemporal manipulation of cAMP
using sACt (Sample et al., 2012). They targeted sACt by fusing
the bicarbonate-activated AC to sequences that target to either
the plasma membrane, cytosol, or the nucleus (Sample et al.,
2012). By monitoring cAMP accumulation or PKA activity with
cytosolic or membrane-tethered sensors, the authors revealed
that cAMP and PKA activity can be localized at either the plasma
membrane or in the nucleus. Modeling the responses of cAMP
and PKA to forskolin and nuclear sAC indicated that a pool of
PKA resides in the nucleus. This prediction was subsequently
conﬁrmed by immunohistochemistry and immunoblotting
(Sample et al., 2012). Another elegant innovation has been to red-
shift FRET-based sensors of cAMP and PKA activity to enable
simultaneous application with other ﬂuorescent sensors. Red-
shifted sensors typically include red ﬂuorescent protein (RFP)
variants such that FRET emission occurs at longer wavelengths
than with typical ﬂuorescent probes (Ni et al., 2011). This
approach was taken to study a cAMP-Ca2+-PKA oscillatory
circuit in MIN6 cells (Ni et al., 2011). Ni et al. (2011) performed
imaging of Fura-2 with either red-shifted AKAR or a red-shifted
Epac-based cAMP sensor. Remarkably, the authors also utilized
a novel dual detector that enables simultaneous PKA activity and
cAMP detection (ICUEPID). Application of these tools showed
that oscillations in MIN6 cells can be triggered by cAMP alone,
and the authors speculate that such oscillations may provide a
way for local PKA activity to be maintained for long periods
of time (Ni et al., 2011). These two studies from the Zhang
laboratory exemplify the potential beneﬁts of combining diﬀerent
categories of tools in novel ways.
Considerations for Experimental Design
When deciding whether to employ one of the tools outlined in
this review, one considers how the strengths, limitations, and
challenges associated with the tool match up with the aims of an
experiment. If spatial aspects of cAMP signaling are the emphasis
of investigation, then the Epac-based cAMP probes (Klarenbeek
et al., 2011; Li et al., 2015) are a good option as they consist
of relatively short sequences that can be directed to subcellular
locations with targeting sequences (Table 1). On the other hand,
if a maxim is placed on temporal resolution, the CNG2 system
may be the better option (Rich et al., 2000; Fagan et al., 2001).
Similarly, PACs such as bPAC (Ryu et al., 2010; Stierl et al., 2011)
allow faster activation and de-activation than the bicarbonate-
activated sACt (Sample et al., 2012). For tandem applications,
the bicarbonate-activated sACt cyclase has the advantage that
there is no concern about unwanted photoactivation when
combined with FRET-based cAMP/PKA sensors (Sample et al.,
2012). Similarly, red-shifted sensors can allow cAMP and PKA
activity sensors to be applied simultaneously (Ni et al., 2011).
The choice of tools will also be dictated by the availability of
specialist equipment. For example, application of FRET-based
sensors typically relies on a confocal microscope with appropriate
lasers. If such a microscope is unavailable then recordings may be
performed using a plate reader (Robinson et al., 2014) although
studies will be limited to the population level following this
approach.
It is important to consider the potential oﬀ-target eﬀects and
distortions that may be caused by the tools. For example, if PKA
is the focus of investigation, it is wise to avoid PKA-based cAMP
sensors that may distort signaling by interacting with native
PKA subunits. Any unwanted cellular changes resulting from
long-term expression of genetically encoded tools can be limited
by using inducible expression systems such as the tetracycline
system (Meyer-Ficca et al., 2004). Another consideration is that
cAMP sensors act as buﬀers for cAMP, potentially altering the
amplitude and duration of cAMP transients in a similar way to
alteration of free Ca2+ transients by dyes such as Fura-2 (Neher,
2008). Buﬀering eﬀects can be at least ameliorated by taking care
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to express cAMP sensors at levels no higher than is necessary
for reliable detection. Finally, one should also bear in mind
that targeting and disruptor sequences may not always behave
as desired. The speciﬁcity of disruptor sequences can be tested
by performing negative control experiments with sequences
such as Ht31-P in which the disruptor helix is destabilized by
incorporation of a central proline (Willoughby et al., 2006). It
is also good practice to image cells to check that localization
sequences have partitioned within the cell as anticipated (Lim
et al., 2007). Overall, the wide range of available tools means that
a good technical solution is at hand for most experimental aims.
Conclusions and Prospects
The genetically encoded tool set for investigating cAMP signaling
has expanded rapidly over the last 15 years. There are now a
multitude of options for monitoring intracellular ﬂuctuations in
cAMP, with Epac-based probes emerging as the most popular
sensor class (DiPilato and Zhang, 2009; Klarenbeek et al., 2011).
AKAR reporters enable PKA activity to be monitored more
directly, while experimenters can artiﬁcially elevate cAMP levels
by photoactivating PACs or stimulating sAC with bicarbonate.
The functionality of these tools can be enhanced by combining
with an impressive array of sequences for modifying protein–
protein interactions and subcellular targeting (Table 1).
There is scope for improving the tools described in this
review, developing novel tools, and combining the tools in new
ways. Biosensors typically improve over time by incorporating
modiﬁcations based on user feedback (Oldach and Zhang,
2014). This process may have reached the point of diminishing
returns for FRET-based sensors and peptides derived from
AKAP anchoring helices, whereas there is more potential
for improvement of the more recently developed PACs and
RSelect subunits. For example, an AC with a synthetic domain
architecture has been shown to be activated by near-infrared
light (Ryu et al., 2014). This PAC is likely to be particularly
advantageous for studies that require deep tissue penetration
(Ryu et al., 2014). It is worth noting that methods for calibrating
FRET-based cAMP reporters are still improving (Koschinski and
Zaccolo, 2015). Genetically encoded sensors that incorporate
Renilla luciferase for Bioluminescence resonance energy transfer
(BRET) imaging (Prinz et al., 2006; Jiang et al., 2007) exhibit
higher maximal signal-to-noise ratios than FRET-based sensors.
Application of BRET sensors in live cell imaging could become
more popular if light detectors can improve to overcome the
relatively low light output of BRET compared to FRET. Although
sequences for disrupting or selectively binding to either side of
the AKAP–PKA interface are advanced (Table 1), no equivalent
sequences exist for interactions mediated by ACs, PDEs, or Epacs.
If the structural and molecular basis of interactions involving
these protein classes can be determined more precisely, it should
be relatively straightforward to develop improved sequences
using established peptide array screening (Alto et al., 2003; Burns-
Hamuro et al., 2003) and directed evolution (Walker-Gray and
Gold, 2015) approaches.
There are currently no existing technologies for activating
PKA or Epac activity with temporal precision. One future avenue
is to genetically encode unnatural amino acids such as caged
lysine using the amber codon TAG (Gautier et al., 2011; Kim
et al., 2013) as a basis for enzyme activation upon illumination
in a similar way to PACs. Future studies may also exploit an
approach for light-gating protein-protein interactions that can
be genetically encoded using sequences from a phytochrome
signaling network (Levskaya et al., 2009). Further combinatorial
possibilities that have been underexploited include fusions of
PACs and sACt with the sequences listed in Table 1. Many
targeting studies have focused on the relation of cAMP signaling
with diﬀerent sub-structural features of cardiomyocytes (Di
Benedetto et al., 2008; Nikolaev et al., 2010). It will be valuable
to perform analogous experiments to probe cAMP signaling in
diﬀerent neuronal compartments. Finally, the ICUEPID sensor
(Ni et al., 2011) sets a precedent for how red-shifting FRET-based
sensors can enable their combination with other technologies that
rely upon illumination.
It is important to question the value of determining how
cAMP signaling processes proceed with high spatial and
temporal detail. The conceptual breakthrough that supported
the development of the ﬁrst β-blocker propranolol (Stapleton
and Black, 1997) indicates how current research targeted at
spatiotemporal cAMP signaling might be useful in the long
term. James Black was inspired to target β-ARs by experiments
conducted by Raymond Ahlquist. Ahlquist established that
there are two major classes of adrenergic receptor, with
β-ARs underpinning responses to norepinephrine in the heart
(Stapleton and Black, 1997). An analogous classiﬁcation of
cAMP signaling processes at the sub-cellular level can provide
a framework for selectively intervening in cAMP signaling
with more precision than drugs that act at the level of the
receptor. Combinatorial application of the genetically encoded
tools described in this review is central to achieving the level
of spatiotemporal detail necessary to open a path to a next
generation of drugs that manipulate cAMP signaling.
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